NVG:NYE-Nuveen Enhanced AMT-Free Municipal Credit Opportunities Fund of Beneficial Interest (USD)

ETF | Medical Distribution | New York Stock Exchange

Last Closing

USD 12.1

Change

-0.05 (-0.41)%

Market Cap

USD 2.84B

Volume

1.21M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Nuveen Enhanced AMT-Free Municipal Credit Opportunities Fund is a closed-end investment company. Its investment objective is to provide attractive level of total return, through long-term capital appreciation and secondarily through income and gains.

Inception Date: 25/03/2002

Primary Benchmark: BBgBarc Municipal Insured TR USD

Primary Index: BBgBarc Municipal TR USD

Gross Expense Ratio: 1.5%

Management Expense Ratio:

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Medical Distribution

Symbol Name Mer Price(Change) Market Cap
COR Cencora Inc. 0.00 %

-0.05 (-0.02%)

USD 44.01B
CAH Cardinal Health Inc 0.00 %

+0.07 (+0.06%)

USD 28.62B
MCK McKesson Corporation 0.00 %

-2.98 (-0.51%)

N/A
OMI Owens & Minor Inc 0.00 %

+0.04 (+0.32%)

N/A

ETFs Containing NVG

MFLX First Trust Flexible Muni.. 0.84 % 0.00 %

+0.07 (+0.41%)

USD 0.01B
PGAL 0.00 % 0.57 %

N/A

N/A
MCEF 0.00 % 0.75 %

N/A

N/A
XMPT 0.00 % 0.40 %

N/A

N/A
CD47:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.37% 40% F 47% F
Dividend Return 6.35% 100% F 78% C+
Total Return 8.71% 40% F 52% F
Trailing 12 Months  
Capital Gain 2.02% 40% F 45% F
Dividend Return 6.32% 100% F 76% C+
Total Return 8.35% 40% F 51% F
Trailing 5 Years  
Capital Gain -27.20% 20% F 21% F
Dividend Return 22.66% 100% F 70% C-
Total Return -4.54% 20% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain -4.21% 20% F 14% F
Dividend Return -1.34% 20% F 15% F
Total Return 2.88% 80% B- 62% D
Risk Return Profile  
Volatility (Standard Deviation) 21.95% 60% D- 50% F
Risk Adjusted Return -6.09% 20% F 17% F
Market Capitalization 2.84B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.